Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB

Biochemical and Biophysical Research Communications

Volumn 434, Issue 4, 2013, Pages 746-752

  Yang, Yongzhi ^a   Ma, Yanlei ^b   Shi, Chenzhang ^a   Chen, Hongqi ^a   Zhang, Huizhen ^a   Chen, Niwei ^a   Zhang, Peng ^b   Wang, Feng ^b   Yang, Jun ^a   Yang, Jianjun ^a   Zhu, Qingchao ^a   Liang, Yong ^a   Wu, Wen ^a   Gao, Renyuan ^a   Yang, Zhe ^a   Zou, Yang ^a   Qin, Huanlong ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Intestinal epithelial barrier; MiR 21; RhoB; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOMODULATING AGENT; INULIN; MESSENGER RNA; MICRORNA 21; PROBIOTIC AGENT; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; STEROID;

ADULT; AGED; ARTICLE; CELL STRAIN CACO 2; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; INTESTINE BIOPSY; INTESTINE EPITHELIUM; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CACO-2 CELLS; COLITIS, ULCERATIVE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; MALE; MICRORNAS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; PERMEABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOB GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, MESSENGER; TIGHT JUNCTIONS; YOUNG ADULT;

EID: 84878193012     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.122     Document Type: Article

References (27)

1. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
2. Pekow J.R., Kwon J.H. MicroRNAs in inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18:187-193.
3. Ordas I., Eckmann L., Talamini M., Baumgart D.C., Sandborn W.J. Ulcerative colitis. Lancet 2012, 380:1606-1619.
4. Gitter A.H., Wullstein F., Fromm M., Schulzke J.D. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001, 121:1320-1328.
5. Salim S.Y., Soderholm J.D. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm. Bowel Dis. 2011, 17:362-381.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Sheedy F.J., Palsson-McDermott E., Hennessy E.J., Martin C., O'Leary J.J., Ruan Q., Johnson D.S., Chen Y., O'Neill L.A. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 2010, 11:141-147.
8. Fabbri M., Paone A., Calore F., Galli R., Gaudio E., Santhanam R., Lovat F., Fadda P., Mao C., Nuovo G.J., Zanesi N., Crawford M., Ozer G.H., Wernicke D., Alder H., Caligiuri M.A., Nana-Sinkam P., Perrotti D., Croce C.M. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. USA 2012, 109:E2110-2116.
9. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., Brant S.R., Chakravarti S., Kwon J.H. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008, 135:1624-1635. e1624.
10. Takagi T., Naito Y., Mizushima K., Hirata I., Yagi N., Tomatsuri N., Ando T., Oyamada Y., Isozaki Y., Hongo H., Uchiyama K., Handa O., Kokura S., Ichikawa H., Yoshikawa T. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J. Gastroenterol. Hepatol. 2010, 25(Suppl. 1):S129-133.
11. Connolly E.C., Van Doorslaer K., Rogler L.E., Rogler C.E. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol. Cancer. Res. 2010, 8:691-700.
12. Sabatel C., Malvaux L., Bovy N., Deroanne C., Lambert V., Gonzalez M.L., Colige A., Rakic J.M., Noel A., Martial J.A., Struman I. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS ONE 2011, 6:e16979.
13. Liu M., Tang Q., Qiu M., Lang N., Li M., Zheng Y., Bi F. MiR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett. 2011, 585:2998-3005.
14. Popoff M.R., Geny B. Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins. Biochim. Biophys. Acta 2009, 1788:797-812.
15. Nusrat A., Giry M., Turner J.R., Colgan S.P., Parkos C.A., Carnes D., Lemichez E., Boquet P., Madara J.L. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc. Natl. Acad. Sci. USA 1995, 92:10629-10633.
16. Goto Y., Kiyono H. Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol. Rev. 2012, 245:147-163.
17. McGuckin M.A., Eri R., Simms L.A., Florin T.H., Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 2009, 15:100-113.
18. Arrieta M.C., Madsen K., Doyle J., Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 2009, 58:41-48.
19. Ye D., Guo S., Al-Sadi R., Ma T.Y. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 2011, 141:1323-1333.
20. Tang Y., Banan A., Forsyth C.B., Fields J.Z., Lau C.K., Zhang L.J., Keshavarzian A. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol. Clin. Exp. Res. 2008, 32:355-364.
21. McKenna L.B., Schug J., Vourekas A., McKenna J.B., Bramswig N.C., Friedman J.R., Kaestner K.H. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010, 139:1654-1664. e1651.
22. Paraskevi A., Theodoropoulos G., Papaconstantinou I., Mantzaris G., Nikiteas N., Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J. Crohns Colitis 2012, 6:900-904.
23. Zahm A.M., Thayu M., Hand N.J., Horner A., Leonard M.B., Friedman J.R. Circulating microRNA is a biomarker of pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 2011, 53:26-33.
24. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
25. Sethupathy P., Megraw M., Hatzigeorgiou A.G. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods 2006, 3:881-886.
26. Aspenstrom P., Fransson A., Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 2004, 377:327-337.
27. Vega F.M., Colomba A., Reymond N., Thomas M., Ridley A.J. RhoB regulates cell migration through altered focal adhesion dynamics. Open Biol. 2012, 2:120076.